Search Results - "Parihar, Ashutosh S."

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Overcoming Acquired Drug Resistance to Cancer Therapies through Targeted STAT3 Inhibition by Singh, Sunanda, Gomez, Hector J, Thakkar, Shreya, Singh, Samara P, Parihar, Ashutosh S

    “…Anti-neoplastic agents for cancer treatment utilize many different mechanisms of action and, when combined, can result in potent inhibition of cancer growth…”
    Get full text
    Journal Article
  2. 2

    A Broad-Based Characterization of a Cell-Penetrating, Single Domain Camelid Bi-Specific Antibody Monomer That Targets STAT3 and KRAS Dependent Cancers by Singh, Sunanda, Murillo, Genoveva, Richner, Justin, Singh, Samara P., Berleth, Erica, Kumar, Vijay, Mehta, Rajendra, Ramiya, Vijay, Parihar, Ashutosh S.

    “…STAT3 and KRAS regulate cell proliferation, survival, apoptosis, cell migration, and angiogenesis. Aberrant expression of STAT3 and mutant active forms of KRAS…”
    Get full text
    Journal Article
  3. 3

    Suppression of Breast Cancer Cell Proliferation by Selective Single-Domain Antibody for Intracellular STAT3 by Singh, Sunanda, Murillo, Genoveva, Chen, Dong, Parihar, Ashutosh S, Mehta, Rajendra G

    “…Background: The serendipitous discovery of heavy-chain antibodies devoid of light chains in camelids and the subsequent development of VHHs (variable region of…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Effects of intermediate-conductance Ca2+-activated K+ channel modulators on human prostate cancer cell proliferation by PARIHAR, Ashutosh S, COGHLAN, Michael J, GOPALAKRISHNAN, Murali, SHIEH, Char-Chang

    Published in European journal of pharmacology (27-06-2003)
    “…The effects of 1-ethyl-2-benzimidazolinone (1-EBIO) and riluzole on human prostate cancer cells, LNCaP and PC-3, were evaluated using rubidium (86Rb(+)) efflux…”
    Get full text
    Journal Article
  6. 6

    Functional analysis of large conductance Ca2(+)-activated K(+) channels: ion flux studies by atomic absorption spectrometry by Parihar, Ashutosh S, Groebe, Duncan R, Scott, Victoria E, Feng, Jianlin, Zhang, Xu-Feng, Warrior, Usha, Gopalakrishnan, Murali, Shieh, Char-Chang

    Published in Assay and drug development technologies (01-10-2003)
    “…Although techniques such as (86)Rb(+) flux provide a sensitive measure of K(+) channel activity, the relatively short half-life and high-energy emission,…”
    Get more information
    Journal Article
  7. 7

    Automated Parallel Oocyte Electrophysiology Test station (POETs): a screening platform for identification of ligand-gated ion channel modulators by Shieh, Char-Chang, Trumbull, Jonathan D, Sarthy, Jay F, McKenna, David G, Parihar, Ashutosh S, Zhang, Xu-Feng, Faltynek, Connie R, Gopalakrishnan, Murali

    Published in Assay and drug development technologies (01-10-2003)
    “…Ligand-gated ion channels (LGICs) play important roles in the regulation of cellular function and signaling and serve as excellent drug targets. However, fast…”
    Get more information
    Journal Article
  8. 8

    Single domain antibody (SBT-100) crosses the blood brain barrier (BBB) and inhibits human glioblastoma by selectively targeting KRAS and P-STAT3 by Singh, Sunanda, Murillo, Genoveva, Singh, Avani, Singh, Samara, Parihar, Meenakshi S, Singh, Anjali H, Mehta, Rajendra, Parihar, Ashutosh S

    Published in Journal of clinical oncology (20-05-2017)
    “…Abstract only e13547 Background: Glioblastoma is difficult to treat malignancy that has a high incidence of KRAS mutations ( > 90%) and hyper-expression of…”
    Get full text
    Journal Article
  9. 9

    Effect of KRAS and P-STAT3 inhibition by SBT-100 on gemcitabine and pancreatic cancer growth in vivo by Singh, Sunanda, Murillo, Genoveva, Singh, Avani, Singh, Samara, Parihar, Meenakshi S, Singh, Anjali H, Mehta, Rajendra, Parihar, Ashutosh S

    Published in Journal of clinical oncology (20-05-2017)
    “…Abstract only e15727 Background: Over 90% of pancreatic cancers have KRAS mutations and hyper-expression of P-STAT3 oncoproteins, which if specifically…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    High throughput electrophysiology using a fully automated, multiplexed recording system by Trumbull, Jonathan D, Maslana, Eugene S, McKenna, David G, Nemcek, Thomas A, Niforatos, Wende, Pan, Jeffrey Y, Parihar, Ashutosh S, Shieh, Char-Chang, Wilkins, Julie A, Briggs, Clark A, Bertrand, Daniel

    Published in Receptors & channels (2003)
    “…The drug discovery process centers around finding and optimizing novel compounds active at therapeutic targets. This process involves direct and indirect…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Species-related pharmacological heterogeneity of histamine H 3 receptors by Ireland-Denny, Lynne, Parihar, Ashutosh S, Miller, Thomas R, Kang, Chae H, Krueger, Kathleen M, Esbenshade, Timothy A, Hancock, Arthur A

    Published in European journal of pharmacology (21-12-2001)
    “…We compared radioligand binding and functional data for histamine H 3 receptor ligands across different tissues or species to evaluate the basis for…”
    Get full text
    Journal Article
  16. 16

    Effects of intermediate-conductance Ca 2+-activated K + channel modulators on human prostate cancer cell proliferation by Parihar, Ashutosh S., Coghlan, Michael J., Gopalakrishnan, Murali, Shieh, Char-Chang

    Published in European journal of pharmacology (2003)
    “…The effects of 1-ethyl-2-benzimidazolinone (1-EBIO) and riluzole on human prostate cancer cells, LNCaP and PC-3, were evaluated using rubidium ( 86Rb +) efflux…”
    Get full text
    Journal Article
  17. 17